ES2091897T3 - Procesamiento in vitro de proteinas de fusion. - Google Patents

Procesamiento in vitro de proteinas de fusion.

Info

Publication number
ES2091897T3
ES2091897T3 ES91810543T ES91810543T ES2091897T3 ES 2091897 T3 ES2091897 T3 ES 2091897T3 ES 91810543 T ES91810543 T ES 91810543T ES 91810543 T ES91810543 T ES 91810543T ES 2091897 T3 ES2091897 T3 ES 2091897T3
Authority
ES
Spain
Prior art keywords
protein
biologically active
amino acid
terminal amino
active protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91810543T
Other languages
English (en)
Inventor
Jutta Dr Heim
Peter Dr Seeboth
Kenji Dr Takabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2091897T3 publication Critical patent/ES2091897T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Abstract

SE PROPORCIONA UN NUEVO METODO PARA LA PRODUCCION DE UNA PROTEINA BIOLOGICAMENTE ACTIVA QUE COMPRENDE EL TRATAMIENTO DE UNA PROTEINA DE FUSION QUE CONSISTE EN 1) UNO O MULTIPLES SEGMENTOS SUCESIVOS DE PROTEINA, CADA UNO COMPUESTO DE LA ANTEDICHA PROTEINA BIOLOGICAMENTE ACTIVA, EL AMINOACIDO C-TERMINAL EL CUAL ESTA UNIDO A UNA SECUENCIA L POLIPEPTIDA DE UNION, Y 2) UN POLIPEPTIDO UNIDO AL AMINOACIDO C-TERMINAL DEL ANTEDICHO SEGMENTO(S) DE PROTEINA SUCESIVO; O CONSISTENTE EN 1) UN POLIPEPTIDO UNIDO A UN AMINOACIDO N-TERMINAL O, 2) MULTIPLES SEGMENTOS DE PROTEINAS SUCESIVOS CADA UNO COMPUESTO DE UNA SECUENCIA L DE POLIPEPTIDO DE UNION Y LA MENCIONADA PROTEINA BIOLOGICAMENTE ACTIVA, CON ENDOPROTEASA DE LEVADURA SOLUBLE YSCF Y CON CARBOXIPEPTIDASA DE LEVADURA SOLUBLE YSC(ALFA), Y AISLANDO LA MENCIONADA PROTEINA BIOLOGICAMENTE ACTIVA.
ES91810543T 1990-07-18 1991-07-09 Procesamiento in vitro de proteinas de fusion. Expired - Lifetime ES2091897T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015825A GB9015825D0 (en) 1990-07-18 1990-07-18 In vitro processing of fusion proteins

Publications (1)

Publication Number Publication Date
ES2091897T3 true ES2091897T3 (es) 1996-11-16

Family

ID=10679295

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91810543T Expired - Lifetime ES2091897T3 (es) 1990-07-18 1991-07-09 Procesamiento in vitro de proteinas de fusion.

Country Status (19)

Country Link
EP (1) EP0467839B1 (es)
JP (1) JP3140488B2 (es)
AT (1) ATE141645T1 (es)
AU (1) AU651830B2 (es)
CA (1) CA2047119C (es)
DE (1) DE69121489T2 (es)
DK (1) DK0467839T3 (es)
ES (1) ES2091897T3 (es)
FI (1) FI106720B (es)
GB (1) GB9015825D0 (es)
GR (1) GR3020840T3 (es)
HU (1) HU216104B (es)
IE (1) IE73209B1 (es)
NO (1) NO303132B1 (es)
NZ (1) NZ238989A (es)
PT (1) PT98332B (es)
SG (1) SG49863A1 (es)
TW (1) TW209247B (es)
ZA (1) ZA915579B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
WO1997023639A1 (fr) * 1995-12-22 1997-07-03 Toray Industries, Inc. Procede de production de proteines fusionnees biologiquement actives
US6800726B1 (en) 1996-11-01 2004-10-05 Pioneer Hi-Bred International, Inc. Proteins with increased levels of essential amino acids
US6265204B1 (en) 1997-01-17 2001-07-24 Genencor International, Inc. DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
GB9716790D0 (en) 1997-08-07 1997-10-15 Creative Peptides Sweden Ab Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
SG11201504771RA (en) 2013-03-06 2015-09-29 Glaxosmithkline Llc Host cells and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
US5010182A (en) * 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
GB9015825D0 (en) 1990-09-05
HU216104B (hu) 1999-04-28
DE69121489D1 (de) 1996-09-26
NO912803D0 (no) 1991-07-17
DK0467839T3 (da) 1996-09-16
NO912803L (no) 1992-01-20
AU651830B2 (en) 1994-08-04
EP0467839B1 (en) 1996-08-21
AU8046391A (en) 1992-01-23
PT98332A (pt) 1992-05-29
FI913405A (fi) 1992-01-19
JPH04229188A (ja) 1992-08-18
ATE141645T1 (de) 1996-09-15
NZ238989A (en) 1992-09-25
TW209247B (es) 1993-07-11
HU912398D0 (en) 1991-12-30
HUT58369A (en) 1992-02-28
IE912501A1 (en) 1992-01-29
GR3020840T3 (en) 1996-11-30
NO303132B1 (no) 1998-06-02
PT98332B (pt) 1999-01-29
FI913405A0 (fi) 1991-07-15
SG49863A1 (en) 2002-03-19
CA2047119A1 (en) 1992-01-19
DE69121489T2 (de) 1997-02-27
CA2047119C (en) 2002-10-08
EP0467839A1 (en) 1992-01-22
FI106720B (fi) 2001-03-30
JP3140488B2 (ja) 2001-03-05
IE73209B1 (en) 1997-05-07
ZA915579B (en) 1992-03-25

Similar Documents

Publication Publication Date Title
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
DK0461165T3 (da) Gærspaltningssystem
DK0815245T3 (da) Bioaktive IL 12 fusionsproteiner
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
CA2089094A1 (en) Expression of recombinant polypeptides with improved purification
ATE188994T1 (de) Methoden zur trans-destabilisierung von spezifischen proteinen in vivo
ZA8860B (en) Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host,process,expression vector and recombinant host therefor and pharmaceutical use thereof
SE8801701D0 (sv) Production technology based on enzymic method
ES2091897T3 (es) Procesamiento in vitro de proteinas de fusion.
DE69233245D1 (de) Verfahren zur Herstellung von Peptiden
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE119914T1 (de) Peptide, deren verwendung als immuno- suppressanten und verfahren zu deren herstellung.
YU69691A (sh) Postupak za pripremu stranih proteina u streptomicetama
WO1999002708A8 (en) Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE3680524D1 (de) Verfahren zur stabilisierung von proteinen.
ATE110775T1 (de) Verfahren zur herstellung von hirudin.
DK53290A (da) Syntetiske gaer-leader-peptider
DE3888078T2 (de) Veränderungsverfahren für Peptide und Proteine.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 467839

Country of ref document: ES